SARS-CoV-2 rS Nanoparticle Vaccine NVX-CoV2373

**Semantic type:** Immunologic Factor|Pharmacologic Substance

**Definition:** A recombinant, nanoparticle-based vaccine consisting of antigen derived from the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) surface antigen spike (S) protein, with potential immunizing activity against SARS-CoV-2. Upon administration, the SARS-CoV-2 rS nanoparticle vaccine NVX-CoV2373 may induce cell-mediated and antibody mediated immune responses against SARS-CoV-2. This may provide active immunization and protection against SARS-CoV-2 infection.

**Synonyms:** - NVX CoV2373 - NVX-COV2373 - NVX-CoV2373 - NVXCoV2373 - Nuvaxovid - SARS-CoV-2 rS Nanoparticle Vaccine